Pre‐treatments enhance the therapeutic effects of mesenchymal stem cells in liver diseases

Liver diseases caused by viral infection, alcohol abuse and metabolic disorders can progress to end‐stage liver failure, liver cirrhosis and liver cancer, which are a growing cause of death worldwide. Although liver transplantation and hepatocyte transplantation are useful strategies to promote live...

Full description

Saved in:

Bibliographic Details
Published in:	Journal of cellular and molecular medicine Vol. 24; no. 1; pp. 40 - 49
Main Authors:	Hu, Chenxia, Wu, Zhongwen, Li, Lanjuan
Format:	Journal Article
Language:	English
Published:	England John Wiley & Sons, Inc 01.01.2020 John Wiley and Sons Inc
Subjects:	Abuse Alcohol abuse Analgesics Animals Anoikis Anti-Inflammatory Agents - pharmacology Apoptosis Bile Cell culture Cell Differentiation Cell Hypoxia Cell therapy Cirrhosis Collagen Cytokeratin Cytokines Drug abuse Fibroblasts gene modification Growth factors Hepatitis Hepatocytes Humans Hypoxia Immunomodulation Immunomodulators Inflammation Kinases Liver cancer Liver cirrhosis liver disease Liver diseases Liver Diseases - pathology Liver Diseases - therapy Liver failure Liver Regeneration Liver transplantation Medical prognosis mesenchymal stem cell Mesenchymal Stem Cell Transplantation - methods Mesenchymal stem cells Mesenchymal Stem Cells - cytology Mesenchymal Stem Cells - drug effects Mesenchyme Metabolic disorders Metabolism Metastasis Microenvironments Oxidative stress Paracrine signalling pre‐treatment Proteins Review Reviews Stem cells Surgical outcomes survival Transplantation Conditioning Tumor necrosis factor-TNF gene modification mesenchymal stem cell liver disease pre-treatment survival
ISSN:	1582-1838, 1582-4934, 1582-4934
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!